Trial intelligence / Profile preview

Norepinephrine and GDFT in Kidney Transplantation

NCT06367205Recruiting

Sponsor
Renji Hospital
Start
Mar 2024
Primary completion
Apr 2026
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of norepinephrine in delayed graft function (DGF) (2 arms), sponsored by Renji Hospital. Primary endpoint: Incidence of Delayed Graft Function at 1 week. Started Mar 2024; status: recruiting.

02

Drugs

norepinephrine
03

Conditions

delayed graft function (DGF)

Beyond the preview

Go deeper on NCT06367205.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06367205.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call